New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Standardized Classification System for Pilonidal Disease and Recurrence Rate after Treatment.
Standardized Classification System for Pilonidal Disease and Recurrence Rate after Treatment. Journal of the American College of Surgeons Chiu, B., Thobani, H., Abrajano, C., Khan, F., Harnish, E., Dalusag, K. 2025Abstract
BACKGROUND: Current classification systems for pilonidal disease do not objectively profile disease severity, limiting their clinical applicability. This study aimed to validate a novel pilonidal disease severity (PDS) staging system by testing its correlation with disease recurrence.STUDY DESIGN: This was a prospective cohort study set at a high-volume, specialized pilonidal care center. All patients presenting with pilonidal disease were included. The main effector under study was PDS stage assigned at initial presentation. Secondary effector variables were an open wound >1 cm on presentation (descriptor W) or prior surgical resection (descriptor R). The primary outcome was pilonidal disease recurrence at 1- and 2-year follow-up.RESULTS: A total of 411 patients met criteria, with 212 and 206 patients completing 1- and 2-year follow-up respectively. Among patients who completed 1-year follow-up, recurrence occurred in 0.0%, 2.3%, 8.3% and 20.8% of patients with PDS stage 0, 1, 2, and 3 disease at initial presentation respectively (log-rank test, p=0.017). At 2-years, recurrence was noted in 0.0%, 4.8%, 12.7% and 27.5% of patients with PDS stage 0, 1, 2, and 3 disease respectively (log-rank test, p=0.010). The presence of an open wound at initial presentation and prior surgical resection were not associated with risk of recurrence (W, p=0.94; R, p=0.98).CONCLUSIONS: This study describes the first staging system for pilonidal disease which correlates with risk of recurrence. Upon further external validation, the PDS staging system may be utilized both clinically to tailor treatment regimens to risk of disease recurrence; and in research to standardize disease severity when comparing different therapeutic interventions.
View details for DOI 10.1097/XCS.0000000000001454
View details for PubMedID 40401769